Independent Dermatological Testing • Legal & Medical Disclaimers
Legal Notice

Terms of Service & Medical Disclaimer

Last Modified: September 14, 2026

1. Acceptance of Terms

By accessing and browsing ClinicalDermaLab ("the Site"), you agree to comply with and be bound by these Terms of Service and all applicable laws and regulations. If you do not agree with any of these terms, you are prohibited from using or accessing this site.

2. Crucial Medical & Dermatological Disclaimer

NOT MEDICAL ADVICE: The evaluations, ingredient breakdowns, scorecards, and commentary published on ClinicalDermaLab are provided strictly for educational and informational purposes. They do not constitute the practice of medicine, medical advice, diagnosis, or personalized treatment planning.

Skincare formulations interact uniquely with individual biological parameters. Factors such as cutaneous barrier condition, compromised skin microbiomes, contact dermatitis allergies, active prescription treatments (such as topical retinoids or oral isotretinoin), and climate affect how your skin responds to products.

Always seek the direct guidance of a board-certified dermatologist, physician, or other qualified healthcare provider with any questions you may have regarding a medical skin condition. Never disregard professional clinical advice or delay seeking it because of something you have read on this website.

3. FTC Affiliate Disclosure

ClinicalDermaLab is a participant in the Amazon Services LLC Associates Program, an affiliate marketing initiative. When you click links on our site that lead to Amazon.com or affiliate retail partners, we may receive a monetary commission on qualifying purchases at zero additional cost to you.

Our affiliate relationships never dictate our testing protocols, ingredient scoring, or clinical judgments. All evaluations are conducted independently by our scientific team.

4. Intellectual Property & Content Rights

All written text, laboratory testing methodology frameworks, custom comparative graphs, and original editorial content on ClinicalDermaLab are the protected intellectual property of ClinicalDermaLab, copyright © 2026.

Product trademarks, brand names, and official packaging visuals (such as EltaMD®, La Roche-Posay®, and Amazon®) are the registered trademarks of their respective brand owners and are utilized here strictly under the principles of nominative fair use for descriptive, educational review purposes.

5. Limitation of Liability

In no event shall ClinicalDermaLab, its medical reviewers, chemists, or contributors be held liable for any damages (including, without limitation, direct, indirect, incidental, or consequential damages resulting from adverse skin reactions, cosmetic allergies, or product misuse) arising out of the use or inability to use the materials on this platform.

6. Modifications to Site Terms

ClinicalDermaLab reserves the right to revise these Terms of Service at any time without prior notice. By continuing to use this site after revisions are published, you agree to be bound by the current version of these Terms.

7. Contact Inquiries

For legal inquiries, copyright notices, or medical board correspondence, please visit our Contact Us page or email legal@clinicaldermalab.com.

Clinical Testing Architecture

Our 4-Pillar Clinical Evaluation Framework

We do not rely on corporate marketing claims or sponsored influencer testimonials. Every formulation on ClinicalDermaLab undergoes a 4-pillar laboratory evaluation protocol combining cutaneous biophysics instrumentation, molecular follicular audits, optical spectrophotometry, and big-data adverse event classification.

100% Anonymous Retail Sourcing
Open-Chamber Tewameter® TM300
Rabbit Ear & Human Biopsy Indices
40,000+ Verified Patient Records
PILLAR 01 Cutaneous Biophysics

TEWL & Epidermal Barrier Recovery

Quantitative measurement of epidermal moisture retention curves and stratum corneum lipid restitution across compromised skin barriers.

Clinical Instrumentation Open-Chamber Tewameter® TM300 & Corneometer® CM825
Evaluation Protocol Baseline, 1-Hour, and 24-Hour Sustained Hydration Kinetics
Efficacy Threshold ≥18% Statistically Significant TEWL Suppression
Explore Barrier Protocol
PILLAR 02 Follicular Toxicology

Comedogenicity & Occlusion Audits

Molecular assessment of every ester, botanical lipid, surfactant, and emulsifier to prevent microcomedone and cystic flare formation.

Clinical Instrumentation Human Follicular Biopsy Data & Rabbit Ear Model (REM)
Evaluation Protocol 0 to 5 Comedogenic Rating & Sebum-Solubility Screening
Safety Threshold Strict Grade 0–1 Standard for Acne & Rosacea Profiles
Explore Comedogenicity Scale
PILLAR 03 Optical Spectrophotometry

UV Filter Dispersion & Photostability

Microscopic evaluation of mineral filter suspension uniformity, Critical Wavelength persistence, and zero white cast across Fitzpatrick types I–VI.

Clinical Instrumentation UV-Vis Spectrophotometer & Cross-Polarized Microscopy
Evaluation Protocol PMMA Plate Thin-Film Assay & 120-Min UV Irradiance Stress
Spectral Threshold Critical Wavelength ≥ 370nm (Broad-Spectrum UVA/UVB)
Explore UV Testing Standards
PILLAR 04 Real-World Epidemiology

Big-Data Patient Meta-Analysis

Algorithmic natural language processing (NLP) of tens of thousands of verified patient ratings to uncover real-world breakouts and allergy risks.

Analytical Engine NLP Clinical Adverse Event Extraction & Sentiment Classifier
Evaluation Protocol 40,000+ Verified Patient Ratings Analyzed per Product
Statistical Threshold <1.8% Breakout Latency & Contact Irritation Rate
Explore Meta-Review Protocol